share_log

Short Interest in Global X Telemedicine & Digital Health ETF (NASDAQ:EDOC) Decreases By 59.0%

Short Interest in Global X Telemedicine & Digital Health ETF (NASDAQ:EDOC) Decreases By 59.0%

Global X遠程醫療和數字健康ETF(納斯達克股票代碼:EDOC)的空頭利息下降了59.0%
Defense World ·  2023/04/27 05:16

Global X Telemedicine & Digital Health ETF (NASDAQ:EDOC – Get Rating) saw a significant decrease in short interest in April. As of April 15th, there was short interest totalling 1,600 shares, a decrease of 59.0% from the March 31st total of 3,900 shares. Based on an average trading volume of 24,900 shares, the short-interest ratio is currently 0.1 days.

Global X遠程醫療和數字健康ETF(納斯達克股票代碼:EDOC — 獲取評級)在4月份的空頭利息大幅下降。截至4月15日,空頭利息總額爲1,600股,較3月31日的3,900股下降了59.0%。根據24,900股的平均交易量,目前的空頭利率爲0.1天。

Institutional Investors Weigh In On Global X Telemedicine & Digital Health ETF

機構投資者關注Global X遠程醫療和數字健康ETF

Hedge funds have recently made changes to their positions in the business. JPMorgan Chase & Co. acquired a new stake in shares of Global X Telemedicine & Digital Health ETF during the first quarter worth about $25,000. OLD Mission Capital LLC acquired a new stake in shares of Global X Telemedicine & Digital Health ETF during the fourth quarter worth about $30,000. Finally, Daiwa Securities Group Inc. boosted its stake in shares of Global X Telemedicine & Digital Health ETF by 5.5% during the fourth quarter. Daiwa Securities Group Inc. now owns 3,805,000 shares of the company's stock worth $44,062,000 after buying an additional 200,000 shares during the period.

對沖基金最近改變了其在業務中的地位。摩根大通在第一季度收購了Global X遠程醫療和數字健康ETF的新股份,價值約25,000美元。OLD Mission Capital LLC在第四季度收購了Global X遠程醫療和數字健康ETF的新股份,價值約3萬美元。最後,大和證券集團公司在第四季度將其持有的Global X遠程醫療和數字健康ETF的股份增加了5.5%。大和證券集團公司在此期間又購買了20萬股股票後,現在擁有該公司3,805,000股股票,價值44,062,000美元。

Get
獲取
Global X Telemedicine & Digital Health ETF
Global X 遠程醫療和數字健康 ETF
alerts:
警報:

Global X Telemedicine & Digital Health ETF Stock Performance

Global X 遠程醫療和數字健康 ETF 股票表現

Shares of EDOC opened at $11.64 on Thursday. Global X Telemedicine & Digital Health ETF has a fifty-two week low of $10.61 and a fifty-two week high of $13.50. The company has a market capitalization of $128.39 million, a price-to-earnings ratio of -14.62 and a beta of 0.88. The firm has a 50-day simple moving average of $11.70 and a 200-day simple moving average of $11.96.

週四,EDOC的股價開盤價爲11.64美元。Global X遠程醫療和數字健康ETF創下52周低點10.61美元,創52周高點13.50美元。該公司的市值爲1.2839億美元,市盈率爲-14.62,beta值爲0.88。該公司的50天簡單移動平均線爲11.70美元,200天簡單移動平均線爲11.96美元。

About Global X Telemedicine & Digital Health ETF

關於 Global X 遠程醫療和數字健康 ETF

(Get Rating)

(獲取評分)

The Global X Telemedicine & Digital Health ETF (EDOC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap weighted index of companies in the global health care industry with high exposure to telemedicine & digital health. EDOC was launched on Jul 29, 2020 and is managed by Global X.

Global X遠程醫療和數字健康ETF(EDOC)是一家交易所交易基金,主要投資於醫療保健股票。該基金追蹤的是全球醫療保健行業中遠程醫療和數字醫療風險敞口高的公司的市值加權指數。EDOC 於 2020 年 7 月 29 日推出,由 Global X 管理。

Featured Articles

精選文章

  • Get a free copy of the StockNews.com research report on Global X Telemedicine & Digital Health ETF (EDOC)
  • Texas Instruments: Another Reason To Take Profits In Chip Stocks?
  • 11 Best Growth Stocks to Buy Now
  • How to Invest in GTE Technology
  • Chipotle Mexican Grill Is Still A Tasty Investment
  • Why Do Tech Stocks Go Down When Interest Rates Rise?
  • 免費獲取 StockNews.com 關於 Global X 遠程醫療和數字健康 ETF (EDOC) 的研究報告的副本
  • 德州儀器:在芯片股中獲利的另一個原因?
  • 現在值得購買的11只最佳成長型股票
  • 如何投資 GTE 技術
  • Chipotle 墨西哥燒烤仍然是一項不錯的投資
  • 爲甚麼利率上升時科技股會下跌?

Receive News & Ratings for Global X Telemedicine & Digital Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X Telemedicine & Digital Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收Global X遠程醫療和數字健康 ETF 的新聞和評級 -在下面輸入您的電子郵件地址,通過Marketbeat.com的免費每日電子郵件時事通訊接收Global X遠程醫療和數字健康ETF及相關公司的最新新聞和分析師評級的簡明每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論